Targeting cancer stem cells by using the nanoparticles.

Area of Science:

• Oncology
• Nanomedicine
• Biotechnology

Background:

• Cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation.
• Current treatments eliminate bulk tumors but not CSCs, necessitating novel therapeutic strategies.
• Targeting CSCs is crucial for developing more effective cancer treatments.

Purpose of the Study:

• To review the therapeutic potential of nanoparticles in targeting cancer stem cells (CSCs).
• To summarize current findings on nanoparticle-based CSC inhibition.
• To highlight nanoparticles' role in overcoming resistance to conventional cancer therapies.

Main Methods:

• Review of existing literature on nanoparticle applications in cancer therapy.
• Analysis of nanoparticle targeting mechanisms for CSCs.
• Summary of studies investigating nanoparticle efficacy against various cancer types and CSCs.

Main Results:

• Nanoparticles effectively inhibit multiple CSC types.
• Targeting involves specific signaling pathways (Wnt/β-catenin, Notch, TGF-β, hedgehog) and markers (ALDHs, CD44, CD90, CD133).
• Nanoparticles demonstrate therapeutic potential across diverse cancer cell types.

Conclusions:

• Nanoparticles offer a promising strategy for selectively targeting and inhibiting cancer stem cells.
• Targeting CSCs with nanoparticles can overcome resistance to conventional treatments.
• Further research into nanoparticle-based therapies could lead to improved clinical outcomes in oncology.